Migraine to Mesenteric Mishap: A Case Report of Ischemic Colitis Due to Sumatriptan
Abstract
Ischemic colitis (IC) results from reduced blood flow to the colon, which can lead to tissue infarction and may be precipitated by medications that induce vasoconstriction. This case involves a 73-year-old female with a history of migraines and chronic back pain who presented with abdominal pain and was diagnosed with severe IC, ultimately requiring subtotal colectomy and ileostomy. The patient had been using nonsteroidal anti-inflammatory drugs for many years, then initiated high doses of the 5-hydroxytryptamine receptor agonist sumatriptan prior to her first episode of IC, suggesting that sumatriptan was the primary etiology. This case represents the patient's third episode of IC, highlighting the importance of thorough medication review in identifying potential etiologies.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.